Market Research Logo

Zealand Pharma A/S - Product Pipeline Review - 2016

Zealand Pharma A/S - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Zealand Pharma A/S - Product Pipeline Review - 2016’, provides an overview of the Zealand Pharma A/S’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Zealand Pharma A/S, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Zealand Pharma A/S
  • The report provides overview of Zealand Pharma A/S including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Zealand Pharma A/S’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Zealand Pharma A/S’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Zealand Pharma A/S’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Zealand Pharma A/S
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Zealand Pharma A/S’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Zealand Pharma A/S Snapshot
Zealand Pharma A/S Overview
Key Information
Key Facts
Zealand Pharma A/S - Research and Development Overview
Key Therapeutic Areas
Zealand Pharma A/S - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Zealand Pharma A/S - Pipeline Products Glance
Zealand Pharma A/S - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Zealand Pharma A/S - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Zealand Pharma A/S - Drug Profiles
ZP-1848
Product Description
Mechanism of Action
R&D Progress
ZP-4207
Product Description
Mechanism of Action
R&D Progress
ZP-2929
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide for Diabetes and Obesity
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptides for Undisclosed Indications
Product Description
Mechanism of Action
R&D Progress
ZP-3022
Product Description
Mechanism of Action
R&D Progress
ZPDI-70
Product Description
Mechanism of Action
R&D Progress
ZPGG-23
Product Description
Mechanism of Action
R&D Progress
ZPGG-72
Product Description
Mechanism of Action
R&D Progress
ZPI-98
Product Description
Mechanism of Action
R&D Progress
Zealand Pharma A/S - Pipeline Analysis
Zealand Pharma A/S - Pipeline Products by Target
Zealand Pharma A/S - Pipeline Products by Route of Administration
Zealand Pharma A/S - Pipeline Products by Molecule Type
Zealand Pharma A/S - Pipeline Products by Mechanism of Action
Zealand Pharma A/S - Recent Pipeline Updates
Zealand Pharma A/S - Dormant Projects
Zealand Pharma A/S - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Zealand Pharma A/S, Key Information
Zealand Pharma A/S, Key Facts
Zealand Pharma A/S - Pipeline by Indication, 2016
Zealand Pharma A/S - Pipeline by Stage of Development, 2016
Zealand Pharma A/S - Monotherapy Products in Pipeline, 2016
Zealand Pharma A/S - Partnered Products in Pipeline, 2016
Zealand Pharma A/S - Partnered Products/ Combination Treatment Modalities, 2016
Zealand Pharma A/S - Out-Licensed Products in Pipeline, 2016
Zealand Pharma A/S - Out-Licensed Products/ Combination Treatment Modalities, 2016
Zealand Pharma A/S - Phase II, 2016
Zealand Pharma A/S - Phase I, 2016
Zealand Pharma A/S - Preclinical, 2016
Zealand Pharma A/S - Pipeline by Target, 2016
Zealand Pharma A/S - Pipeline by Route of Administration, 2016
Zealand Pharma A/S - Pipeline by Molecule Type, 2016
Zealand Pharma A/S - Pipeline Products by Mechanism of Action, 2016
Zealand Pharma A/S - Recent Pipeline Updates, 2016
Zealand Pharma A/S - Dormant Developmental Projects,2016
List of Figures
Zealand Pharma A/S - Pipeline by Indication,
Zealand Pharma A/S - Pipeline by Stage of Development,
Zealand Pharma A/S - Monotherapy Products in Pipeline,
Zealand Pharma A/S - Partnered Products in Pipeline,
Zealand Pharma A/S - Out-Licensed Products in Pipeline,
Zealand Pharma A/S - Pipeline by Target,
Zealand Pharma A/S - Pipeline by Route of Administration,
Zealand Pharma A/S - Pipeline by Molecule Type,
Zealand Pharma A/S - Pipeline Products by Mechanism of Action,

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report